About TGR BioSciences
TGR BioSciences is a company based in Adelaide (Australia) founded in 2001 was acquired by Abcam in November 2019.. TGR BioSciences has raised $2.24 million across 1 funding round from investors including Abcam, Nanyang Ventures and SYGNIS. TGR BioSciences offers products and services including SureFire Ultra and CaptSure. TGR BioSciences operates in a competitive market with competitors including Matriks Biotek, IBL International, Optofluidic Bioassay, Elisabeth Biosciences and Lifespan Technologies, among others.
- Headquarter Adelaide, Australia
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Tgr Biosciences Pty Ltd
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TGR BioSciences
TGR BioSciences offers a comprehensive portfolio of products and services, including SureFire Ultra and CaptSure. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides high-throughput analysis of phosphoproteins using no-wash technology.
Enables improved assay speed and performance in various formats.
Funding Insights of TGR BioSciences
TGR BioSciences has successfully raised a total of $2.24M through 1 strategic funding round. The most recent funding activity was a Series A round of $2.24 million completed in August 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $2.2M
-
First Round
First Round
(17 Aug 2005)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2005 | Amount | Series A - TGR BioSciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in TGR BioSciences
TGR BioSciences has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Abcam, Nanyang Ventures and SYGNIS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Biological reagents and antibodies are developed for life science research.
|
Founded Year | Domain | Location | |
|
SYGNIS provides molecular biology reagents for research and laboratory applications.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by TGR BioSciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - TGR BioSciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tgr Biosciences Comparisons
Competitors of TGR BioSciences
TGR BioSciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Matriks Biotek, IBL International, Optofluidic Bioassay, Elisabeth Biosciences and Lifespan Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
ELISA kits for monitoring biological drugs are developed and offered.
|
|
| domain | founded_year | HQ Location |
Immunoassays and antibodies are supplied for diagnostic applications in labs.
|
|
| domain | founded_year | HQ Location |
Proprietary microfluidic ELISA plates are provided for bioassays.
|
|
| domain | founded_year | HQ Location |
Elisabeth Biosciences manufactures and distributes ELISA kits for diagnostic applications.
|
|
| domain | founded_year | HQ Location |
Develops and sells ELISA kits for detecting carbohydrates in medical diagnostics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about TGR BioSciences
When was TGR BioSciences founded?
TGR BioSciences was founded in 2001 and raised its 1st funding round 4 years after it was founded.
Where is TGR BioSciences located?
TGR BioSciences is headquartered in Adelaide, Australia. It is registered at Adelaide, South Australia, Australia.
Is TGR BioSciences a funded company?
TGR BioSciences is a funded company, having raised a total of $2.24M across 1 funding round to date. The company's 1st funding round was a Series A of $2.24M, raised on Aug 17, 2005.
What does TGR BioSciences do?
TGR BioSciences specializes in immunoassay technology and provides solutions for cell-based research applications. Its flagship product, SureFire is used for high throughput analysis of phosphoproteins using a no-wash, bead-based technology. SureFire provides a toolbox for measuring endogenous signalling proteins in a homogeneous format and there are 60 SureFire kits currently available, each measuring a different cell signalling target. TGR has also launched CaptSure that is a one-wash ELISA platform with manufacturing and user advantages.
Who are the top competitors of TGR BioSciences?
TGR BioSciences's top competitors include IBL International, Matriks Biotek and Optofluidic Bioassay.
What products or services does TGR BioSciences offer?
TGR BioSciences offers SureFire Ultra and CaptSure.